Macular scan OCT could be used for glaucoma

Article

Macular scan OCT could be used for the diagnosis and management of glaucoma.

Macular scan OCT could be used for the diagnosis and management of glaucoma.

Dr Whitney Boling and her team, Department of Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, Indiana, studied the OCT macula scans and automated visual field (VF) defects of 127 eyes of 127 glaucoma patients.

The superior inner and outer sectors and the inferior inner and outer sectors were recorded by macular scan OCT. Superior outer, superior inner, inferior inner, and inferior outer rows were used to determine VFs. OCT macular scan sectors and VF rows were compared using the Spearman correlation.

There were statistically significant structural relationships between all macular parameters and the related VF defects. The highest correlations were between the inferior outer macular thickness and the superior outer VF region, the inferior inner macular and the superior inner VF region, the superior inner macula and the inferior inner VF region, and the superior outer macular and the inferior outer VF region.

Macular scan OCT should be considered as a tool for the diagnosis and management of glaucoma, due to the predictable and significant structural relationship between macular thickness and VF defects.

To read the abstract please visit the Journal of Glaucoma.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.